Beyond Weight Loss: Semaglutide Could Curb Alcohol Cravings According to USC Study - SciTechDaily
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from USC suggests that semaglutide—the drug marketed as Ozempic for diabetes and Wegovy for obesity—may also help reduce alcohol consumptio…
Comments